drugset / Trial / NCT00527202

Efficacy Study of Botox to Treat Neuropathic Pain

NCT00527202 ↗

Phase 4 Completed 29 enrolled Hospital Ambroise Paré Paris
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Objectives : to investigate the analgesic effects and safety of intradermal botulinum toxin A injection in the treatment of focal painful neuropathies (eg, postherpetic neuralgia, nerve trauma)

Timeline

Start
2004-06
Primary completion
2007-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 200 iu Other